Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ashwin Pinto

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
BMC Health Services Research|July 13, 2022
Cost-minimisation analysis of plasma exchange versus IVIg in the treatment of autoimmune neurological conditionsTara Klemencic Kozul, Anna Yudina, Carley Donovan, et al.
Muscle & Nerve|May 8, 2002
The action of Lambert-Eaton myasthenic syndrome immunoglobulin G on cloned human voltage-gated calcium channelsAshwin Pinto, Kazuo Iwasa, Claire Newland, et al.
BMC Neurology|January 11, 2025
Amyotrophic lateral sclerosis in a patient with chronic lymphocytic leukaemia and drug related sarcoid-like reactionJoumana Freiha, Effie Grand, Ben Marshall, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|June 11, 2009
Early and marked benefit with GPi DBS for Lubag syndrome presenting with rapidly progressive life-threatening dystoniaIrene Martinez-Torres, Patricia Limousin, Steve Tisch, et al.
Neurology and Therapy|May 15, 2025
What Patients Don't Say and Physicians Don't Ask: A Needs Assessment in Myasthenia Gravis Integrating Patient and Healthcare Professional PerspectivesCornelia Reyes Acosta, Ivo Vlaev, Alexis Rodriguez, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|May 23, 2019
The relationships between symptoms, disability, perceived health and quality of life in amyotrophic lateral sclerosis/motor neuron diseaseCarolyn Anne Young, John Ealing, Christopher McDermott, et al.
Frontiers in Neurology|January 29, 2026
ENGAGE: Analyzing the value of virtual reality in a patient-centric immersive learning program in myasthenia gravis for healthcare professionalsIna Weisshardt, Cornelia Reyes Acosta, Trishna Chauhan, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|June 30, 2020
Measuring quality of life in ALS/MND: validation of the WHOQOL-BREFCarolyn A Young, Roger Mills, Ammar Al-Chalabi, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|January 11, 2025
Efgartigimod efficacy and safety in refractory myasthenia gravis: UK's first real-world experienceJoana Moniz Dionísio, Philip Ambrose, Georgina Burke, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|May 8, 2013
Management of sialorrhoea in motor neuron disease: a survey of current UK practiceEsther V Hobson, Alexander McGeachan, Ammar Al-Chalabi, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
BMC Health Services Research|July 13, 2022
Cost-minimisation analysis of plasma exchange versus IVIg in the treatment of autoimmune neurological conditionsTara Klemencic Kozul, Anna Yudina, Carley Donovan, et al.
Muscle & Nerve|May 8, 2002
The action of Lambert-Eaton myasthenic syndrome immunoglobulin G on cloned human voltage-gated calcium channelsAshwin Pinto, Kazuo Iwasa, Claire Newland, et al.
BMC Neurology|January 11, 2025
Amyotrophic lateral sclerosis in a patient with chronic lymphocytic leukaemia and drug related sarcoid-like reactionJoumana Freiha, Effie Grand, Ben Marshall, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|June 11, 2009
Early and marked benefit with GPi DBS for Lubag syndrome presenting with rapidly progressive life-threatening dystoniaIrene Martinez-Torres, Patricia Limousin, Steve Tisch, et al.
Neurology and Therapy|May 15, 2025
What Patients Don't Say and Physicians Don't Ask: A Needs Assessment in Myasthenia Gravis Integrating Patient and Healthcare Professional PerspectivesCornelia Reyes Acosta, Ivo Vlaev, Alexis Rodriguez, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|May 23, 2019
The relationships between symptoms, disability, perceived health and quality of life in amyotrophic lateral sclerosis/motor neuron diseaseCarolyn Anne Young, John Ealing, Christopher McDermott, et al.
Frontiers in Neurology|January 29, 2026
ENGAGE: Analyzing the value of virtual reality in a patient-centric immersive learning program in myasthenia gravis for healthcare professionalsIna Weisshardt, Cornelia Reyes Acosta, Trishna Chauhan, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|June 30, 2020
Measuring quality of life in ALS/MND: validation of the WHOQOL-BREFCarolyn A Young, Roger Mills, Ammar Al-Chalabi, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|January 11, 2025
Efgartigimod efficacy and safety in refractory myasthenia gravis: UK's first real-world experienceJoana Moniz Dionísio, Philip Ambrose, Georgina Burke, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|May 8, 2013
Management of sialorrhoea in motor neuron disease: a survey of current UK practiceEsther V Hobson, Alexander McGeachan, Ammar Al-Chalabi, et al.
Pageof 3